Brind.
  1. Johnson & Johnson successfully spun off Kenvue to focus on core business, while FED policy signals affect market perception of JNJ.
  2. Kimberly-Clark is acquiring Kenvue's consumer health business, which includes Listerine and Neutrogena staples, following Kenvue's spin-off from J&J.

Kimberly-Clark is acquiring Kenvue in a buyout, which includes the sale of Neutrogena and the inclusion of Listerine in Essential Health sales.

3 reports, 2 independent Updated Aug 10
Gone quiet
Reports
3
Developments
1
Repetition
67%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Kimberly-Clark is acquiring Kenvue in a buyout, which includes the sale of Neutrogena and the inclusion of Listerine in Essential Health sales.

Who's involved

What this event is mainly about
Kimberly-ClarkNeutrogenaListerine

Keep exploring

Part of

Kimberly-Clark is acquiring Kenvue's consumer health business, which includes Listerine and Neutrogena staples, following Kenvue's spin-off from J&J. All 1 developments

Within Johnson & Johnson successfully spun off Kenvue to focus on core business, while FED policy signals affect market perception of JNJ.

The entities involved

Related events

Coverage

Newest first; wire copies grouped
1 more outlet ran the same wire story